跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,811 条关于
“Biosimilar User Fee Act”
全部
32,811
临床试验
25,144
药物
1,826
机构
165
资讯
5,676
9个月前
FDA Launches Public Input Process for BsUFA IV Reauthorization to Shape Biosimilar Regulatory Framework Through 2032
去年
FDA Accepts Biosimilar Application for BAT2506, Proposed Golimumab Alternative
去年
FDA Sets October 2025 Decision Date for Xbrane's Ranibizumab Biosimilar Application
去年
FDA Initiates PDUFA VIII Reauthorization Process with Public Meeting and Assessment Report
去年
FDA Sets 2026 User Fee Rates for Generic and Animal Drug Programs with Inflation Adjustments
上个月
FDA Unveils FY 2027 User Fee Rates: PDUFA Revenue Target Rises 6%, MDUFA Jumps 14%
去年
FDA Rehires Key Pharma User Fee Negotiators After Mass Layoffs Threaten Drug Review Process
去年
FDA Deputy Commissioner Signals Potential Overhaul of PDUFA Reauthorization Structure
去年
FDA Sets PDUFA Date for Neffy Nasal Spray and Approves Crinecerfont for CAH Treatment
9个月前
FDA Proposes Higher User Fees for Overseas Phase I Trials to Boost Domestic Drug Development
第 1 页,共 568 页
上一页
下一页